Skip to content
2000
image of Clinical Characteristics and Prognostic Factors Associated with Herpes Zoster in Patients with Malignant Tumors: A Systematic Review and Meta-analysis

Abstract

Background

Herpes zoster (HZ) is a common complication in patients with malignant tumors (MT), impacting prognosis. Immunocompromised states due to malignancy or treatment increase HZ risk. However, comprehensive assessments of HZ's clinical features and its impact on prognosis in these patients are limited, general conclusions are challenging, prompting a systematic review and meta-analysis to better understand the relative risk of HZ in malignancy.

Objective

To assess the clinical features and prognostic factors of HZ in cancer patients through systematic review and meta-analysis. The study aimed to calculate the relative risk of HZ in malignancy and analyze factors affecting prognosis, such as age, gender, tumor type, and treatment.

Methods

A systematic search in PubMed (2016-2024) identified studies on HZ and malignancy. Two reviewers independently screened and selected studies, extracting data on study characteristics, population demographics, and outcomes. Statistical heterogeneity across the studies was addressed using random-effects models, while subgroup analyses were performed to identify potential sources of heterogeneity.

Results

Out of the 633 records reviewed, 13 studies satisfied the eligibility criteria and were incorporated into the meta-analysis. The combined relative risk for any type of cancer was found to be 1.82(95% CI: 1.29,2.57). The combined relative risk for any solid tumors was 1.63(95% CI: 1.08,2.46). The combined relative risk for any haematological cancer was 3.43(95% CI: 1.33,8.86). The combined analysis of all treatment modalities (including Radiotherapy, Chemotherapy, Immunosuppression, HSCT) shows a significant overall effect with a risk ratio of 1.78(95%CI: 1.59,2.00).

Conclusion

Cancer patients have increased HZ risk due to immunosuppression from the malignancy and its treatment, especially in hematological cancers and those undergoing stem cell transplantation.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206350399250324183333
2025-04-07
2025-09-18

  • From This Site

    /content/journals/acamc/10.2174/0118715206350399250324183333
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Cohen J.I. Herpes Zoster. N. Engl. J. Med. 2013 369 3 255 263 10.1056/NEJMcp1302674 23863052
    [Google Scholar]
  2. Gilden D.H. Kleinschmidt-DeMasters B.K. LaGuardia J.J. Mahalingam R. Cohrs R.J. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 2000 342 9 635 645 10.1056/NEJM200003023420906 10699164
    [Google Scholar]
  3. Lin H.C. Chao Y.H. Wu K.H. Yen T.Y. Hsu Y.L. Hsieh T.H. Wei H.M. Wu J.L. Muo C.H. Hwang K.P. Peng C.T. Lin C.C. Li T.C. Increased risk of herpes zoster in children with cancer. Medicine 2016 95 30 e4037 10.1097/MD.0000000000004037 27472677
    [Google Scholar]
  4. Woo Y.R. Jung Y.J. Kim J.S. Kim M. Park Y.M. Min C.K. Kim D.W. Park H.J. Cutaneous comorbidities in patients with multiple myeloma. Medicine 2018 97 43 e12825 10.1097/MD.0000000000012825 30412074
    [Google Scholar]
  5. Asada H. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study. Vaccine 2019 37 44 6776 6781 10.1016/j.vaccine.2019.09.031 31543415
    [Google Scholar]
  6. Lu L. Suo L. Li J. Pang X. A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China. Hum. Vaccin. Immunother. 2018 14 11 1 4 10.1080/21645515.2018.1489193 30059639
    [Google Scholar]
  7. Page M.J. Moher D. Bossuyt P.M. Boutron I. Hoffmann T.C. Mulrow C.D. Shamseer L. Tetzlaff J.M. Akl E.A. Brennan S.E. Chou R. Glanville J. Grimshaw J.M. Hróbjartsson A. Lalu M.M. Li T. Loder E.W. Mayo-Wilson E. McDonald S. McGuinness L.A. Stewart L.A. Thomas J. Tricco A.C. Welch V.A. Whiting P. McKenzie J.E. PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. BMJ 2021 372 n160 10.1136/bmj.n160 33781993
    [Google Scholar]
  8. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010 25 9 603 605 10.1007/s10654‑010‑9491‑z 20652370
    [Google Scholar]
  9. Schmidt S.A.J. Mor A. Schønheyder H.C. Sørensen H.T. Dekkers O.M. Cronin-Fenton D. Herpes zoster as a marker of occult cancer: A systematic review and meta-analysis. J. Infect. 2017 74 3 215 235 10.1016/j.jinf.2016.11.005 27845154
    [Google Scholar]
  10. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev. 1987 9 1 1 30 10.1093/oxfordjournals.epirev.a036298 3678409
    [Google Scholar]
  11. Egger M. Smith G.D. Schneider M. Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 7109 629 634 10.1136/bmj.315.7109.629 9310563
    [Google Scholar]
  12. Buchan S.A. Daneman N. Wang J. Garber G. Wormsbecker A.E. Wilson S.E. Deeks S.L. Incidence of hospitalizations and emergency department visits for herpes zoster in immunocompromised and immunocompetent adults in ontario, canada, 2002–2016. Clin. Infect. Dis. 2020 71 1 22 29 10.1093/cid/ciz769 31436814
    [Google Scholar]
  13. Choi H.G. Zehnder J.L. Lee Y.K. Lim H. Kim M. Increased risk of lymphoid malignancy in patients with herpes zoster: A longitudinal follow-up study using a national cohort. BMC Cancer 2019 19 1 1148 10.1186/s12885‑019‑6349‑y 31775678
    [Google Scholar]
  14. Vázquez G.Y. Cabanillas F. Concepción J.R. Miranda D.O.L. Incidence and risk factors for developing herpes zoster among a cohort of patients diagnosed with lymphoma at a community cancer center. Clin. Lymphoma Myeloma Leuk. 2019 19 3 e153 e158 10.1016/j.clml.2018.12.001 30655095
    [Google Scholar]
  15. Kao Y.S. Hsu Y. Hsu C. Radiotherapy increases the incidence of herpes zoster in oral cavity cancer patients – a national population-based cohort study. In Vivo 2021 35 6 3547 3553 10.21873/invivo.12657 34697193
    [Google Scholar]
  16. Kim Y.J. Lee C.N. Lee M.S. Lee J.H. Lee J.Y. Han K. Park Y.M. Recurrence rate of herpes zoster and its Risk factors: A population-based cohort study. J. Korean Med. Sci. 2019 34 2 e1 10.3346/jkms.2019.34.e1 30636941
    [Google Scholar]
  17. Lee P.Y. Lai J.N. Chen S.W. Lin Y.C. Chiu L.T. Wei Y.T. Radiotherapy combined with chemotherapy increases the risk of herpes zoster in patients with gynecological cancers: A nationwide cohort study. J. Gynecol. Oncol. 2021 32 2 e13 10.3802/jgo.2021.32.e13 33300312
    [Google Scholar]
  18. Liao K.F. Kuo Y.H. Lai S.W. Increased risk of herpes zoster in cancer patients. J. Infect. Dis. 2019 220 9 1542 1543 10.1093/infdis/jiz329 31242285
    [Google Scholar]
  19. Mahale P. Yanik E.L. Engels E.A. Herpes Zoster and Risk of Cancer in the Elderly U.S. Population. Cancer Epidemiol. Biomarkers Prev. 2016 25 1 28 35 10.1158/1055‑9965.EPI‑15‑1033 26578536
    [Google Scholar]
  20. Qian J. Heywood A.E. Karki S. Banks E. Macartney K. Chantrill L. Liu B. Risk of herpes zoster prior to and following cancer diagnosis and treatment: A population-based prospective cohort study. J. Infect. Dis. 2019 220 1 3 11 10.1093/infdis/jiy625 30544213
    [Google Scholar]
  21. Tsao Y.H. Hsieh C.J. Juan Y.S. Lee Y.C. Shen J.T. Wang H.S. Jhan J.H. Geng J.H. Herpes zoster and the subsequent risk of prostate cancer in an Asian population. Medicine 2020 99 40 e22441 10.1097/MD.0000000000022441 33019427
    [Google Scholar]
  22. Shimizuguchi T. Sekiya N. Hara K. Taguchi A. Nakajima Y. Miyake Y. Shibata Y. Taguchi K. Ogawa H. Ito K. Karasawa K. Radiation therapy and the risk of herpes zoster in patients with cancer. Cancer 2020 126 15 3552 3559 10.1002/cncr.32926 32412661
    [Google Scholar]
  23. Mao J. McPheeters J.T. Finelli L. Healthcare utilization and costs among patients with herpes zoster and solid tumor malignancy on chemotherapy. Medicine 2017 96 48 e8746 10.1097/MD.0000000000008746 29310348
    [Google Scholar]
  24. Hansson E. Forbes H.J. Langan S.M. Smeeth L. Bhaskaran K. Herpes zoster risk after 21 specific cancers: Population-based case–control study. Br. J. Cancer 2017 116 12 1643 1651 10.1038/bjc.2017.124 28463961
    [Google Scholar]
  25. Yanni E.A. Ferreira G. Guennec M. Hahi E.Y. Ghachi E.A. Haguinet F. Espie E. Bianco V. Burden of herpes zoster in 16 selected immunocompromised populations in England: A cohort study in the Clinical Practice Research Datalink 2000–2012. BMJ Open 2018 8 6 e020528 10.1136/bmjopen‑2017‑020528 29880565
    [Google Scholar]
  26. Yenikomshian M.A. Guignard A.P. Haguinet F. LaCasce A.S. Skarin A.T. Trahey A. Karner P. Duh M.S. The epidemiology of herpes zoster and its complications in Medicare cancer patients. BMC Infect. Dis. 2015 15 1 106 10.1186/s12879‑015‑0810‑6 25888128
    [Google Scholar]
  27. Chen S.Y. Suaya J.A. Li Q. Galindo C.M. Misurski D. Burstin S. Levin M.J. Incidence of herpes zoster in patients with altered immune function. Infection 2014 42 2 325 334 10.1007/s15010‑013‑0550‑8 24214127
    [Google Scholar]
  28. Forbes H.J. Bhaskaran K. Thomas S.L. Smeeth L. Clayton T. Langan S.M. Quantification of risk factors for herpes zoster: Population based case-control study. BMJ 2014 348 g2911 10.1136/bmj.g2911 25134101
    [Google Scholar]
  29. Imafuku S. Matsuki T. Mizukami A. Goto Y. Souza D.S. Jégou C. Bianco V. Rosillon D. Ito C. Curran D. Holl K. Burden of herpes zoster in the japanese population with immunocompromised/chronic disease conditions: Results from a cohort study claims database from 2005–2014. Dermatol. Ther. 2019 9 1 117 133 10.1007/s13555‑018‑0268‑8 30456446
    [Google Scholar]
  30. Jih J.S. Chen Y.J. Lin M.W. Chen Y.C. Chen T.J. Huang Y.L. Chen C.C. Lee D.D. Chang Y.T. Wang W.J. Liu H.N. Epidemiological features and costs of herpes zoster in Taiwan: A national study 2000 to 2006. Acta Derm. Venereol. 2009 89 6 612 616 10.2340/00015555‑0729 19997693
    [Google Scholar]
  31. Pinchinat S. Cebrián-Cuenca A.M. Bricout H. Johnson R.W. Similar herpes zoster incidence across Europe: Results from a systematic literature review. BMC Infect. Dis. 2013 13 1 170 10.1186/1471‑2334‑13‑170 23574765
    [Google Scholar]
  32. Feldman S. Hughes W.T. Kim H.Y. Herpes zoster in children with cancer. Arch. Pediatr. Adolesc. Med. 1973 126 2 178 184 10.1001/archpedi.1973.02110190156009 4353308
    [Google Scholar]
  33. Menon B.S. Maziah W.W.M. Herpes zoster in children with cancer. Malays. J. Pathol. 2001 23 1 47 48 16329548
    [Google Scholar]
  34. Sorensen G.V. RosthOj S. Würtz M. Danielsen T.K. The epidemiology of herpes zoster in 226 children with acute lymphoblastic leukemia. Ped. Blood. Can. 2011 57 6 993 7 https://pubmed.ncbi.nlm.nih.gov/21254379/
    [Google Scholar]
  35. Guess H.A. Broughton D.D. Melton L.J. III Kurland L.T. Epidemiology of herpes zoster in children and adolescents: A population-based study. Pediatrics 1985 76 4 512 517 10.1542/peds.76.4.512 3863086
    [Google Scholar]
  36. Habel L.A. Ray G.T. Silverberg M.J. Horberg M.A. Yawn B.P. Castillo A.L. Quesenberry C.P. Jr Li Y. Sadier P. Tran T.N. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol. Biomarkers Prev. 2013 22 1 82 90 10.1158/1055‑9965.EPI‑12‑0815 23118142
    [Google Scholar]
  37. Smitten A.L. Choi H.K. Hochberg M.C. Suissa S. Simon T.A. Testa M.A. Chan K.A. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Care Res. 2007 57 8 1431 1438 10.1002/art.23112 18050184
    [Google Scholar]
  38. Thomas S.L. Hall A.J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis. 2004 4 1 26 33 10.1016/S1473‑3099(03)00857‑0 14720565
    [Google Scholar]
  39. Wu K.H. Tsai C. Wu H.P. Sieber M. Peng C.T. Chao Y.H. Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: Enhance hematopoiesis after cord blood transplantation. Cell Transplant. 2013 22 11 2041 2051 10.3727/096368912X663533 24165586
    [Google Scholar]
  40. Wu K.H. Wu H.P. Chan C.K. Hwang S.M. Peng C.T. Chao Y.H. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: From bench to bedsides. Cell Transplant. 2013 22 4 723 729 10.3727/096368912X655217 23068433
    [Google Scholar]
  41. Li Y. An Z. Yin D. Liu Y. Huang Z. Xu J. Ma Y. Tu Q. Li Q. Wang H. Disease burden due to herpes zoster among population aged ≥50 years old in china: A community based retrospective survey. PLoS One 2016 11 4 e0152660 10.1371/journal.pone.0152660 27055179
    [Google Scholar]
  42. Yang Y. Chen R. Xu J. Li Q. Xu X. Ha S. Song W. Tan J. Xu F. Kan H. The effects of ambient temperature on outpatient visits for varicella and herpes zoster in Shanghai, China: A time-series study. J. Am. Acad. Dermatol. 2015 73 4 660 665 10.1016/j.jaad.2015.07.015 26277211
    [Google Scholar]
  43. Garnett G.P. Cox M.J. Bundy D.A.P. Didier J.M. Catharine J.S. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol. Infect. 1993 110 2 361 372 10.1017/S0950268800068308 8386097
    [Google Scholar]
  44. Hart P.H. Norval M. Byrne S.N. Rhodes L.E. Exposure to ultraviolet radiation in the modulation of human diseases. Annu. Rev. Pathol. 2019 14 1 55 81 10.1146/annurev‑pathmechdis‑012418‑012809 30125148
    [Google Scholar]
  45. Huang E. Wells C. A. 2014 The ground state of innate immune responsiveness is determined at the interface of genetic, epigenetic, and environmental influences. J. Immunol. 93 1 13 9 10.4049/jimmunol.1303410
    [Google Scholar]
  46. MacGillivray D.M. Kollmann T.R. The role of environmental factors in modulating immune responses in early life. Front. Immunol. 2014 5 434 10.3389/fimmu.2014.00434 25309535
    [Google Scholar]
/content/journals/acamc/10.2174/0118715206350399250324183333
Loading
Clinical Characteristics and Prognostic Factors Associated with Herpes Zoster in Patients with Malignant Tumors: A Systematic Review and Meta-analysis
Bentham Science Publishers ; https://doi.org/10.2174/0118715206350399250324183333
/content/journals/acamc/10.2174/0118715206350399250324183333
/content/journals/acamc/10.2174/0118715206350399250324183333
Loading

Data & Media loading...

Supplements

file format download Download

  • Article Type:     Research Article
Keywords: cancer patients ; malignant tumors ; immune function ; Herpes zoster ; meta-analysis ; systematic review

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test